Latest Medicinal Cannabis News
Aurora Cannabis Achieves Significant Progress in Disease Resistance Research
As a leading global medical cannabis company, advancements in breeding, testing and production trials for powdery mildew-resistant cultivars reinforce Aurora's leadership in cannabis science EDMONTON, AB, Jan. 14, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce significant progress in its powdery mildew (PM)... Read more
MediPharm Labs to Enter New Market with Costa Rica Supply Agreement
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the signing of a definitive supply agreement with Remidose Aerosols Inc. (“Remidose”) for the shipment of GMP-certified medicinal cannabis products to Costa... Read more
IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors
TORONTO and GLIL YAM, Israel, Jan. 5, 2026 /CNW/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), medical cannabis company with operations in Israel and Germany, announced today that Mr. Alon Dayan has been appointed to the Company's board of directors effective December 31, 2025. Mr. Dayan, who is currently the Chief Executive Officer of KeepZone AI Inc., a position he has held since 2025,... Read more
FLUENT Announces Sale of Pennsylvania Operations Strengthening Balance Sheet and Sharpening Focus on Core Growth Markets
TAMPA, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced that it has completed the sale of its Pennsylvania operations to HIVE Holdings, Inc., effective December 31, 2025 for US$12.5 million in cash. The proceeds from the transaction were used to reduce FLUENT’s outstanding debt, which is expected to meaningfully enhance its balance sheet,... Read more
IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research
Engages Exclusive Financial Advisors for U.S. Opportunities and Potential Divestitures of German and Israeli Operations TORONTO and GLIL YAM, Israel, Dec. 30, 2025 /CNW/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), medical cannabis company with operations in Israel and Germany, today announced that it is actively evaluating certain strategic opportunities to expand its operations into the United... Read more
1933 Industries Achieves Positive Income in Q1 2026, Marking Third Consecutive Profitable Quarter
VANCOUVER, BC / ACCESS Newswire / December 22, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its first quarter financial results ("Q1 2026") for the three months ended October 31, 2025 and 2024. All amounts expressed are in Canadian dollars. The Company owns 100%[1] of Alternative Medicine... Read more
WEED Forms Strategic Partnership with Remergify to Design, Develop, Program, Deploy & Coordinate the Launch of WEEDCoin & BUDZCoin in the AI/Crypto/Blockchain Universe...
Remergify Inc., a leading strategic advisory firm specializing in asset monetization and blockchain integration, to use its expertise in blockchain, tokenization and AI expertise to spearhead the tokenization of WEEDs launch into the world of Crypto! TUCSON, ARIZONA / ACCESS Newswire / December 16, 2025 / WEED Inc. ("WEED" or the "Company") is a global cannabis & hemp bioresearch company based in the USA,... Read more
MediPharm Labs Completes First Shipment to France
TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the completion of the Company's first shipment to France. This milestone follows a production agreement with an international medicinal cannabis organization. This... Read more
1933 Industries Announces Year End 2025 Financial Results and Reports Positive Income
VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries")(CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its audited annual financial results for the years ended July 31, 2025 and 2024 ("Fiscal 2025"). All amounts expressed are in Canadian dollars. The Company owns 100% [1] of Alternative Medicine Association... Read more
FLUENT Reports Third Quarter 2025 Results
Focused on Margin Expansion, Operational Efficiency, and Strategic Market Positioning Ahead of Buffalo, New York and Rosa, Florida Premium Indoor Facility Activations in Q4 2025 TAMPA, Fla., Nov. 28, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the... Read more
FLUENT Cannabis Announces Opening of New Dispensary in Brandon, Florida
Grand Opening Celebration will be Saturday, November 22, 2025 TAMPA, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced that its new 2,800 sq ft Brandon, FL dispensary is now open for patients, with a grand opening celebration set for Saturday, November 22, 2025. The new store opening reflects FLUENT’s ongoing strategy to expand in... Read more
FLUENT Cannabis Launches Bag-O 7g Ground Flower in Florida, Expanding Patient Choice and Convenience
TAMPA, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the launch of its new Bag-O 7-gram Ground Flower product line in Florida dispensaries, further strengthening the Company’s portfolio and offering patients more convenient, ready-to-use options for dry herb consumption. The product is grounded in a simple value proposition that... Read more
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
Q3 2025 Revenue of $11.4 Million, an Increase of 17% over Q3 2024 83% Growth in Year-Over-Year Revenue for International Medical Cannabis International Medical sales now 56% of Total Revenue Increased Cash Balance of $10.6 Million at the end of Q3 2025 Operating Expenses Decreased 19% Year-Over-Year Management to Host Conference Call / Webcast on November 13th, 2025 at 10:00 am... Read more
IM Cannabis Reports Third Quarter 2025 Financial Results
TORONTO and GLIL YAM, Israel, Nov. 13, 2025 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the third quarter and nine months ended September 30, 2025. All amounts are reported in Canadian dollars and compared to the quarter and nine months ended September 30, 2024, unless otherwise stated. Q3 2025... Read more
CV Sciences Reports Third Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2025. Third Quarter 2025 and Recent Financial and Operating... Read more
Akanda Researching Security Requirements for Full Cultivation License
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") is researching the security requirements and next steps for a full cultivation license through its cannabis operating subsidiary. Recently, the Company extended its option on its British Columbia asset for an additional two years. While the Company currently operates under its hemp cultivation license,... Read more
FLUENT Completes First Harvests at Rosa Facility, Advancing Its Growth Strategy and Proving Operational Execution
TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the successful completion of the first series of harvests at Rosa, the company’s newest Florida indoor cultivation facility. The inaugural harvests represent another significant operational milestone as FLUENT continues to expand its premium production capacity and elevate the... Read more
FLUENT Unifies New York Retail Network with Rebranding of Manhattan and White Plains Dispensaries
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the rebranding of its Manhattan and White Plains dispensaries, marking the second and third adult-use locations in New York to officially transition under the FLUENT banner. The White Plains and Manhattan rebrands follow FLUENT’s acquisition of RIV Capital on December 19, 2024 and the... Read more
Akanda Increasing Its Cannabis Investment
Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), through its cannabis operating subsidiary, has furthered its cannabis investment by extending its option on its British Columbia asset for two additional years. The Company has been working on obtaining its full cultivation license for a variety of potential products containing THC, but currently it is... Read more
Innocan Pharma: Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
Innovative Chronic Pain Treatment Receives allowance for IP Protection in Japan's World Third Largest Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, Oct. 15, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its patent for LPT-CBD was allowed in... Read more
PharmaCielo Completes La Margarita Land Sale, Repays Banco Agrario Loan, Strengthens Balance Sheet, Completes Audit
TORONTO and RIONEGRO, Colombia, Oct. 06, 2025 (GLOBE NEWSWIRE) -- PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTC: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced the closing of the sale of its La Margarita property in Carmen de Viboral, Antioquia, Colombia, to... Read more
Akanda's First Towers and Fiber Taps Into Mexico's $7 Billion Telecom Buildout
TORONTO, ON / ACCESS Newswire / October 1, 2025 / Scarcity is usually a problem in business. For Akanda Corp. (NASDAQ:AKAN), it's an advantage. The company sits on one of the leanest floats on the Nasdaq, barely 728,000 shares after its reverse split. That scarcity means every contract, every tower, and every stretch of fiber deployed carries more weight than it would anywhere else. First Towers & Fiber (FTF),... Read more
Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical...
NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray Craft portfolio in Germany with five new... Read more
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
HERZLIYA, Israel and CALGARY, AB, Sept. 18, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce its ongoing collaboration with Freedom Farm, a sanctuary dedicated to rescuing animals that were expelled from the industrial farms as a result of the animals having physical... Read more
Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains
Tilray Affirms Continued Commitment to German Healthcare and Expanding Patient and Pharmacy Access in Europe's Largest Medical Cannabis Market LONDON and NEUMÜNSTER, Germany, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare... Read more
FLUENT Reports Second Quarter 2025 Results
TAMPA, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the second quarter ended June 30, 2025. Unless otherwise indicated, all financial results are presented in U.S. dollars. Management Commentary “While Q2 results fell below... Read more
Body and Mind Announces Agreement to Divest from New Jersey
Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - August 25, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC: BMMJ) (the "Company" or "BaM") is pleased to announce the Company's wholly owned subsidiary, DEP Nevada, Inc. ("DEP") has entered into a Purchase Agreement with Ascend New Jersey, LLC (the "Purchaser"), whereby DEP, which owns 100% of BaM Body and Mind Dispensary NJ, Inc. ("BAM NJ") agrees to... Read more
FLUENT Announces Exclusive Cultivation Partnership with Connected Cannabis at New Facility in Buffalo, New York
Connected brands, including Connected Cannabis, AlienLabs and Smoken Promises branded products, to be distributed through the ENTOURAGE wholesale network and FLUENT retail stores NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the commencement of operations at its new 68,000+ square-foot indoor cultivation facility in Buffalo,... Read more
High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH
Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component... Read more
MediPharm Labs Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
Q2 Revenue of $11.8 Million, an Increase of 14% over Q2 2024 50% Growth in Revenue for International Medical Cannabis International Medical sales now 57% of Total Revenue Cash Balance of $10.4 Million at the end of Q2, Increased from $8.4 Million in Q1 2025 Management to Host Conference Call / Webcast on August 14th, 2025 at 10:00 am ET TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) --... Read more
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health... Read more
MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States
MediPharm Labs holds unique US Food and Drug Administration (FDA) site registration in relation to the manufacturing and release of pharmaceutical cannabis products. MediPharm is the only US FDA Audited purpose-built commercial cannabis facility in Canada. One of a handful globally. The possible rescheduling of cannabis in the US opens new opportunities for MediPharm in categories where the Company... Read more
CV Sciences Reports Second Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2025. Second Quarter 2025 and Recent Financial and Operating... Read more
IM Cannabis Reports Second Quarter 2025 Financial Results
IMC Delivers Strong Profit and Margin Growth Despite Revenue Impact from External Challenges in Q2 2025 TORONTO and GLIL YAM, Israel, Aug. 12, 2025 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2025. All amounts are reported in Canadian dollars and compared to the quarter... Read more
IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million
TORONTO and GLIL YAM, Israel, July 31, 2025 /CNW/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, effective July 30, 2025 (the "Closing Date") it has closed a private placement offering (the "Offering"), through the issuance of 2,050,000 units (each a "Unit") at a price per Unit of... Read more
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specializing in precision-based cannabinoids, is pleased to announce it has launched the new Shake & Puff CBN THC Nighttime Inhaler in Canada. This innovative product expands MediPharm’s leading CBN oil product portfolio and builds on... Read more